Factors associated with expression of extrapyramidal symptoms in users of atypical antipsychotics

被引：0
|
作者：
Susana Barbosa Ribeiro
Aurigena Antunes de Araújo
Caroline Addison Xavier Medeiros
Katarina Melo Chaves
Maria do Socorro Costa Feitosa Alves
Antonio Gouveia Oliveira
Rand Randall Martins
机构：
[1] Universidade Federal do Rio Grande do Norte,Postgraduate Program in Pharmaceutical Science
[2] Universidade Federal do Rio Grande Norte,Department of Biophysics and Pharmacology
[3] Universidade Federal do Rio Grande Norte,Postgraduate Programs in Biological Science/Postgraduate Programs RENORBIO
[4] Universidade Federal do Rio Grande Norte,Postgraduate Program in Public Health
[5] Universidade Federal do Rio Grande do Norte,Pharmacy Department
来源：
European Journal of Clinical Pharmacology | 2017年 / 73卷
关键词：
Schizophrenia; Second-generation antipsychotics; Extrapyramidal symptoms; Adjunctive therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：351 / 355
页数：4
相关论文
共 50 条
  • [1] Factors associated with expression of extrapyramidal symptoms in users of atypical antipsychotics
    Ribeiro, Susana Barbosa
    de Araujo, Aurigena Antunes
    Xavier Medeiros, Caroline Addison
    Chaves, Katarina Melo
    Costa Feitosa Alves, Maria do Socorro
    Oliveira, Antonio Gouveia
    Martins, Rand Randall
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (03) : 351 - 355
  • [2] Extrapyramidal symptoms with atypical antipsychotics - Incidence, prevention and management
    Pierre, JM
    DRUG SAFETY, 2005, 28 (03) : 191 - 208
  • [3] Side effects of atypical antipsychotics: Extrapyramidal symptoms and the metabolic syndrome
    Shirzadi, Arshia A.
    Ghaemi, S. Nassir
    HARVARD REVIEW OF PSYCHIATRY, 2006, 14 (03) : 152 - 164
  • [4] Extrapyramidal symptoms with atypical antipsychotics:: A [123I]IBZM SPECT study
    De Mendelssohn, A
    Küfferle, B
    Asenbaum, S
    Tauscher-Wisniewski, S
    Kasper, S
    Tauscher, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S287 - S287
  • [5] Atypical antipsychotics in the treatment of schizophrenia - Paper underrates patients' experience of extrapyramidal symptoms
    Kerwin, R
    BRITISH MEDICAL JOURNAL, 2001, 322 (7291): : 926 - 927
  • [6] Typical and atypical antipsychotics in adolescent schizophrenia: Efficacy, tolerability, and differential sensitivity to extrapyramidal symptoms
    Lewis, R
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1998, 43 (06): : 596 - 604
  • [7] Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia
    Weng, Jiajun
    Zhang, Yan
    Li, Huafang
    She, Yifeng
    Yu, Wenjuan
    GENERAL PSYCHIATRY, 2019, 32 (01)
  • [8] Atypical antipsychotics not devoid of extrapyramidal side effects
    Reactions Weekly, 2007, 1164 (1) : 3 - 3
  • [9] The efficacy and extrapyramidal side effects of the atypical antipsychotics
    Glick, ID
    Davis, JM
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 229 - 229
  • [10] Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptoms
    Boloc, Daniel
    Rodriguez, Natalia
    Torres, Teresa
    Garcia-Cerro, Susana
    Parellada, Mara
    Saiz-Ruiz, Jeronimo
    Cuesta, Manuel J.
    Bernardo, Miquel
    Gasso, Patricia
    Lafuente, Amalia
    Mas, Sergi
    Albert Arnaiz, Joan
    PSYCHOPHARMACOLOGY, 2020, 237 (07) : 2151 - 2159
12345